Clinical Trials in Atlanta

Showing 521-540 of 19,805 trials

SOC Chemotherapy +/- Tocilizumab for Triple Negative and ER-low Breast Cancers

NCT05846789

This is a randomized Phase II study of standard of care (SOC) chemotherapy monotherapy vs. SOC chemotherapy combined with tocilizumab in in Black and non-Black patients with metastatic triple negative or ER low breast cancer.

Metastatic Breast CancerTriple Negative Breast CancerEstrogen-receptor-low Breast Cancer

Kathy Miller168 participantsStarted Jul 2024

Atlanta, Georgia, United States • Carmel, Indiana, United States • Indianapolis, Indiana, United States +3 more locations

Active Not RecruitingPhase 1< 1 mile

A Study of Teclistamab With Other Anticancer Therapies in Participants With Multiple Myeloma

NCT04722146

The purpose of this study is to characterize the safety and tolerability of teclistamab when administered in different combination regimen and to identify the optimal dose(s) of teclistamab combination regimens.

Multiple Myeloma

Janssen Research & Development, LLC140 participantsStarted Mar 2021

Birmingham, Alabama, United States • San Francisco, California, United States • Denver, Colorado, United States +24 more locations

SOC Chemotherapy +/- Tocilizumab for Triple Negative and ER-low Breast Cancers

A Study of Teclistamab With Other Anticancer Therapies in Participants With Multiple Myeloma

Find Trials by Condition in Atlanta

Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer

A Study to Evaluate the Efficacy and Safety of Esketamine for Reduction of Symptoms of Major Depressive Disorder

A Study to Evaluate TAR-210 Versus Intravesical Chemotherapy Treatment in Participants With High Risk Non-Muscle-Invasive Bladder Cancer

A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Chronic Migraine

The Effects of Chiropractic in a Population With High Central Adiposity

The Effects of Chiropractic Care on Inflammation and Quality of Life in People Living With HIV

A Phase II Study of Pemigatinib Plus Durvalumab in Previously Treated Advanced Intrahepatic Cholangiocarcinoma Patients With FGFR-2 Fusion or Rearrangement

A Study of Navenibart (STAR-0215) in Participants With Hereditary Angioedema

IKS014 in Advanced Solid Tumors That Express HER2

A Study of REC-1245 in Participants With Unresectable, Locally Advanced, or Metastatic Cancer

A Study of JNJ-80948543, a T-cell Redirecting CD79b x CD20 x CD3 Trispecific Antibody, in Participants With Non-Hodgkin Lymphoma (NHL) and Chronic Lymphocytic Leukemia (CLL)

Study to Evaluate Safety, Tolerability, and Optimal Dose of Candidate GBM Vaccine VBI-1901 in Recurrent GBM Subjects

A Clinical Trial for Participants With DEE to Assess Efficacy, Safety, Tolerability, and PK of Relutrigine

A Study to Evaluate the Efficacy and Safety of Factor IX Gene Therapy With PF-06838435 in Adult Males With Moderately Severe to Severe Hemophilia B

An Extension Study of Donidalorsen (IONIS-PKK-LRx) in Participants With Hereditary Angioedema

Acute Normovolemic Hemodilution in High Risk Cardiac Surgery Patients.

Safety and Efficacy of EIK1001 in Combo With Pembro Versus Placebo and Pembro as First-Line Therapy in Patients With Advanced Melanoma.

Efficacy and Safety of Benralizumab in EGPA Compared to Mepolizumab.